Circular RNA Circ_0008043 promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating the microRNA (miR)-326/RAB21 axis

References

• Llovet JM, Castet F, Heikenwalder M, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2021. DOI:10.1038/s41571-021-00573-2
   PubMed Web of Science ®Google Scholar
• Calderaro J, Ziol M, Paradis V, et al. Molecular and histological correlations in liver cancer. J Hepatol. 2019;71(3):616–630.
   PubMed Web of Science ®Google Scholar
• Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245.
   Web of Science ®Google Scholar
• Ferrarese A, Sciarrone SS, Pellone M, et al. Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma. Minerva Gastroenterol. 2021;67(1):4–10.
   Google Scholar
• Colagrande S, Inghilesi AL, Aburas S, et al. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(34):7645–7659.
   PubMed Web of Science ®Google Scholar
• Imamura I. Prognostic efficacy of treatment for extrahepatic metastasis after surgical treatment of hepatocellular carcinoma. Kurume Med J. 2003;50(1–2):41–48.
   PubMedGoogle Scholar
• Chen S, Cao Q, Wen W, et al. Targeted therapy for hepatocellular carcinoma: challenges and opportunities. Cancer Lett. 2019;460:1–9.
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xie Q, He D, et al. Circular RNA: new star, new hope in cancer. BMC Cancer. 2018;18(1):834.
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6.
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319–336.
   PubMed Web of Science ®Google Scholar
• Lei B, Tian Z, Fan W, et al. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019 Jan 1;16(2):292–301.
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Cho HS, et al. Epigenetic associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers (Basel). 2020;12(9):2622.
   PubMed Web of Science ®Google Scholar
• Jadideslam G, Ansarin K, Sakhinia E, et al. The MicroRNA-326: autoimmune diseases, diagnostic biomarker, and therapeutic target. J Cell Physiol. 2018;233(12):9209–9222.
   PubMed Web of Science ®Google Scholar
• Tang Q, Chen Z, Zhao L, et al. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY). 2019;11(22):9982–9999.
   PubMedGoogle Scholar
• Wang G, Yuan J, Cai X, et al. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med. 2020;10(2):e113.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wei X, Zhang W, et al. MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways. Eur J Pharmacol. 2020;872:172941.
   PubMed Web of Science ®Google Scholar
• Jiang J, Lin H, Shi S, et al. Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis. Thorac Cancer. 2020;11(11):3181–3192.
   PubMed Web of Science ®Google Scholar
• Wu Y, Cheng K, Liang W, et al. lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis. Oncol Lett. 2020;20(4):105.
   PubMed Web of Science ®Google Scholar
• Ji S, Zhang B, Kong Y, et al. miR-326 inhibits gastric cancer cell growth through downregulating NOB1. Oncol Res. 2017;25(6):853–861.
   PubMed Web of Science ®Google Scholar
• Hu S, Ran Y, Chen W, et al. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Oncol Rep. 2017;38(3):1569–1578.
   PubMed Web of Science ®Google Scholar
• Constantino-Jonapa LA, Hernández-Ramírez VI, Osorio-Trujillo C, et al. EhRab21 associates with the Golgi apparatus in Entamoeba histolytica. Parasitol Res. 2020;119(5):1629–1640.
   PubMed Web of Science ®Google Scholar
• Tang BL, Ng EL. Rabs and cancer cell motility. Cell Motil Cytoskeleton. 2009;66(7):365–370.
   PubMed Web of Science ®Google Scholar
• Song D, Ye L, Xu Z, et al. CircRNA hsa_circ_0030018 regulates the development of glioma via regulating the miR-1297/RAB21 axis. Neoplasma. 2021;68(2):391–403.
   PubMed Web of Science ®Google Scholar
• Anand S, Khan MA, Khushman M, et al. Comprehensive analysis of expression, clinicopathological association and potential prognostic significance of RABs in pancreatic cancer. Int J Mol Sci. 2020;21(15):5580.
   PubMed Web of Science ®Google Scholar
• Ma X, Wang Z, Ren H, et al. Long non-coding RNA GAS5 suppresses tumor progression and enhances the radiosensitivity of prostate cancer through the miR-320a/RAB21 axis. Cancer Manag Res. 2020;12:8833–8845.
   PubMed Web of Science ®Google Scholar
• Zhang W, Mao K, Liu S, et al. miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3. J Recept Signal Transduct Res. 2021;41(2):180–187.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li Y, Feng X, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12(1):414–425.
   PubMed Web of Science ®Google Scholar
• Ding B, Fan W, Lou W. hsa_circ_0001955 enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis. Mol Ther Nucleic Acids. 2020;22:445–455.
   PubMedGoogle Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10(12):945.
   PubMed Web of Science ®Google Scholar
• Wei X, Zheng W, Tian P, et al. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA. Cell Cycle. 2020;19(7):817–824.
   PubMed Web of Science ®Google Scholar
• Zou H, Xu X, Luo L, et al. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622. Cell Cycle. 2019;18(19):2398–2413.
   PubMed Web of Science ®Google Scholar
• Pan YJ, Wan J, Wang CB. MiR-326: promising biomarker for cancer. Cancer Manag Res. 2019;11:10411–10418.
   PubMed Web of Science ®Google Scholar
• Wei J, Meng G, Wu J, et al. MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1alpha and elevating VEGFA. Bioengineered. 2021. DOI:10.1080/21655979.2021.1993718
   Web of Science ®Google Scholar
• Jia B, Yin X, Wang Y, et al. CircRNA-PTN sponges miR-326 to promote proliferation in hepatocellular carcinoma. Onco Targets Ther. 2020;13:4893–4903.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Wu C, Wang J, et al. LncRNA SNHG3 promotes hepatocellular tumorigenesis by targeting miR-326. Tohoku J Exp Med. 2019;249(1):43–56.
   PubMed Web of Science ®Google Scholar
• Ge J, Chen Q, Liu B, et al. Knockdown of Rab21 inhibits proliferation and induces apoptosis in human glioma cells. Cell Mol Biol Lett. 2017;22:30.
   PubMed Web of Science ®Google Scholar
• Yousaf M, Ali M. Modulation of ABCG2 surface expression by Rab5 and Rab21 to overcome multidrug resistance in cancer cells. Xenobiotica. 2020;50(8):988–996.
   PubMed Web of Science ®Google Scholar